Literature DB >> 12966544

Genomic and phylogenetic analysis of hepatitis C virus isolates: a survey of 535 strains circulating in southern France.

Catherine Tamalet1, Philippe Colson, Hervé Tissot-Dupont, Mireille Henry, Christian Tourres, Natacha Tivoli, Danielle Botta, Isabelle Ravaux, Isabelle Poizot-Martin, Nouara Yahi.   

Abstract

The present study examines the distribution of Hepatitis C virus (HCV) genotypes in Marseille, France in 2001-2002 and evaluates the efficiency of two in house direct sequence PCR protocols based on 5'NC analysis or NS5B analysis. By 5'NC sequencing, the distribution of 535 HCV strains derived from patients attending gastroenterology and AIDS referral centers, or dialysis units was as follows: 33% were infected by genotype 1a; 26% by 1b; 7% by 2; 22% by 3a; 10.7% by 4. In univariate analysis, HCV distribution was associated with age and source of infection, whereas in multivariate analysis only injecting drug use was an independent determinant for genotype distribution. Among the 535 specimens submitted to 5'NC direct sequencing, 18% could not be classified accurately into subtypes. A subset of 187 samples was amplified efficiently and sequenced by targeting the NS5B region of the viral genome. The two methods yielded concordant results in 70% of cases. Specimens unsubtypeable or misclassified most frequently by 5'NC analysis were type 1b and subtypes 2a/2c and 4a/4c. The data show that 5'NC direct sequence analysis is a sensitive method to identify genotypes in all cases, but that it can lead to subtyping misclassification (in particular, subtype 1b and 1a) or doubtful results (in particular subtypes 2a/2c and 4a/4c). Conversely, NS5B direct sequence assay, based on phylogenetic analysis, allowed better discrimination between subtypes. These two approaches are complementary and should be made available in clinical laboratories to ensure a reliable survey of HCV strains. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966544     DOI: 10.1002/jmv.10505

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France.

Authors:  Jean-François Cantaloube; Pierre Gallian; Houssam Attoui; Philippe Biagini; Philippe De Micco; Xavier de Lamballerie
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus.

Authors:  Masako Okada; Hoang Hai; Akihiro Tamori; Sawako Uchida-Kobayashi; Masaru Enomoto; Hiromitsu Kumada; Norifumi Kawada
Journal:  Clin J Gastroenterol       Date:  2018-11-16

3.  Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study.

Authors:  M Raptopoulou; G Touloumi; D Tzourmakliotis; G Nikolopoulou; M Dimopoulou; G Giannoulis; T Vasiliadis; A Skoutelis; O Anagnostou; G Hatzis; S Manolakopoulos
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

4.  Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.

Authors:  Michael O Baclig; Veronica F Chan; John Donnie A Ramos; Juliet Gopez-Cervantes; Filipinas F Natividad
Journal:  Int J Mol Epidemiol Genet       Date:  2010-07-07

5.  Broad differences between the COBAS ampliprep total nucleic acid isolation-COBAS TaqMan 48 hepatitis C virus (HCV) and COBAS HCV monitor v2.0 assays for quantification of serum HCV RNA of non-1 genotypes.

Authors:  Philippe Colson; Anne Motte; Catherine Tamalet
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions.

Authors:  Elisa Martró; Victoria González; Andrew J Buckton; Verónica Saludes; Gema Fernández; Lurdes Matas; Ramón Planas; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

Review 7.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

8.  HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations.

Authors:  Lorenzo Uccellini; Fan-Chen Tseng; Alessandro Monaco; Fatma M Shebl; Ruth Pfeiffer; Myhanh Dotrang; Dianna Buckett; Michael P Busch; Ena Wang; Brian R Edlin; Francesco M Marincola; Thomas R O'Brien
Journal:  Hepatology       Date:  2012-06-01       Impact factor: 17.425

9.  Hepatitis C virus genotyping methods: evaluation of AmpliSens(®) HCV-1/2/3-FRT compared to sequencing method.

Authors:  Nurul Azmawati Mohamed; Zetti Zainol Rashid; Kon Ken Wong
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

10.  Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.

Authors:  Syria Laperche; Françoise Lunel; Jacques Izopet; Sophie Alain; Paul Dény; Gilles Duverlie; Catherine Gaudy; Jean-Michel Pawlotsky; Jean-Christophe Plantier; Bruno Pozzetto; Vincent Thibault; François Tosetti; Jean-Jacques Lefrère
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.